Sulfatide antibody-mediated neuropathy: an analysis of clinical characteristics and immunotherapeutic responses

Sulfatide antibodies may attack peripheral nerves and the brainstem. The prognosis is relatively good for most patients by immunotherapy. Patients with sole sulfatide antibody exhibited more severe symptoms and electrophysiological issues but responded better to treatment.